It has also been suggested to have a higher threshold of HbA1c of 8% for older adults (age 75 years and older) and HbA1c of 7% for others to avert the most significant number of DALYs from insulin treatment by balancing the risk of hypoglycemia against the benefit of reducing microvascular complications [38]. This evidence concerns the gene INS and Hypoglycemia.